Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study

[1]  R. Price,et al.  The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis , 2022, medRxiv.

[2]  H. Win,et al.  Determinants of primaquine and carboxyprimaquine exposures in children and adults with Plasmodium vivax malaria , 2021, medRxiv.

[3]  M. White,et al.  Tafenoquine for the prevention of Plasmodium vivax malaria relapse. , 2021, The Lancet. Microbe.

[4]  T. Bousema,et al.  Chloroquine Potentiates Primaquine Activity against Active and Latent Hepatic Plasmodia Ex Vivo: Potentials and Pitfalls , 2020, Antimicrobial Agents and Chemotherapy.

[5]  R. Price,et al.  Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis , 2020, The American journal of tropical medicine and hygiene.

[6]  A. Bacchieri,et al.  Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation , 2019, Scientific Reports.

[7]  F. Nosten,et al.  Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria , 2019, The New England journal of medicine.

[8]  W. Monteiro,et al.  Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria , 2019, The New England journal of medicine.

[9]  N. Goyal,et al.  Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial , 2018, Antimicrobial Agents and Chemotherapy.

[10]  I. Elyazar,et al.  Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria , 2018, JAMA network open.

[11]  R. Price,et al.  Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study , 2017, PLoS medicine.

[12]  N. Goyal,et al.  Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects , 2016, Antimicrobial Agents and Chemotherapy.

[13]  I. Elyazar,et al.  Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia , 2015, BMC Medicine.

[14]  R. Price,et al.  Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis , 2014, The Lancet. Infectious diseases.

[15]  David L. Smith,et al.  Geographical variation in Plasmodium vivax relapse , 2014, Malaria Journal.

[16]  S. Krudsood,et al.  Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study , 2014, The Lancet.

[17]  N. Gogtay,et al.  Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. , 2013, The Cochrane database of systematic reviews.

[18]  E. Tjitra,et al.  A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia , 2013, The Journal of infectious diseases.

[19]  I. Elyazar,et al.  Randomized, Open-Label Trial of Primaquine against Vivax Malaria Relapse in Indonesia , 2012, Antimicrobial Agents and Chemotherapy.

[20]  Anand P. Patil,et al.  Plasmodium vivax Malaria Endemicity in Indonesia in 2010 , 2012, PloS one.

[21]  D. Kyle,et al.  Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta) , 2011, Malaria Journal.

[22]  Purnomo,et al.  Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. , 2003, The American journal of tropical medicine and hygiene.

[23]  K. Rieckmann,et al.  WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. , 1997, The American journal of tropical medicine and hygiene.

[24]  W E Collins,et al.  Primaquine resistance in Plasmodium vivax. , 1996, The American journal of tropical medicine and hygiene.

[25]  R. J. Dern,et al.  Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. , 1955, The Journal of laboratory and clinical medicine.

[26]  M. D. Young,et al.  Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. , 1950, Journal. National Malaria Society.

[27]  Winarno,et al.  The distribution and bionomics of anopheles malaria vector mosquitoes in Indonesia. , 2013, Advances in parasitology.